Drug industry
Article Abstract:
Statistics of some of the companies in the Drug industry and their securities rankings as of April 22, 2005 are furnished. Investors have overreacted to some of the reports of Cox-2 inhibitors. Investments in the companies of this sector in fact have good short-term and long-term prospects.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2005
Forecasts, trends, outlooks, Industry Overview, Industry forecasts
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Ivax Corp
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Ivax Corp. from 1988 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Company sales and earnings, Company earnings/profit, IVAX Corp.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Pharmaceutical industry, Securities, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.